Related Experiment Video
Updated: Jul 25, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Ketamine: stimulating antidepressant treatment?
Gin S Malhi1, Yulisha Byrow2, Frederick Cassidy3
1, MD, Department of Psychiatry, Kolling Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, St Leonards, NSW, Australia.
Bjpsych Open
|October 6, 2016
Summary
Ketamine rapidly improves depression symptoms, increasing its off-label use. Experts worldwide are reviewing its potential for depression treatment, considering evidence and clinical experience for future research strategies.
Area of Science:
- Neuroscience and Psychiatry
- Pharmacology of Novel Antidepressants
- Mood Disorder Treatment Strategies
Background:
- Growing off-label use of ketamine for depression due to rapid symptom amelioration.
- Need for robust corroboration of initial promising results and understanding long-term effects.
- Expert opinions are crucial for evaluating ketamine's role in depression management.
Discussion:
- Synthesis of global expert perspectives on ketamine for treating mood disorders.
- Balancing rapid antidepressant effects against uncertainties in long-term administration.
- Clinical experience and evidence-based review of ketamine's therapeutic potential.
Key Insights:
- Ketamine shows significant promise for rapid relief of depressive symptoms, including in treatment-resistant cases.
- Long-term safety and efficacy data for ketamine in depression require further investigation.
- Expert consensus is forming regarding the judicious use of ketamine in specific patient populations.
Outlook:
- Future research should focus on long-term outcomes, optimal dosing, and patient selection for ketamine therapy.
- Development of standardized protocols for ketamine administration in clinical practice.
- Continued global collaboration to advance understanding and application of ketamine for depression.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...